News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dana-Farber Cancer Institute Researchers Utilize InforSense Limited's ClinicalSense to Streamline Data Analysis


4/16/2008 10:46:38 AM

LONDON and CAMBRIDGE, MA--(Marketwire - April 16, 2008) - InforSense Ltd., the leading provider of embedded enterprise intelligence, today announced that it has signed a three year collaboration agreement with Dana-Farber Cancer Institute. The deal includes InforSense's ClinicalSense cohort selection and clinical decision support product, and its wider translational research capabilities to support improved disease understanding and patient care in oncology.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES